Heart failure with preserved ejection fraction: A systemic disorder?;L'insuffisance cardiaque à fraction d'éjection préservée : Une maladie de système ?

Revue de Medecine Interne

Volumn 33, Issue 7, 2012, Pages 370-380

  Ennezat, P V ^a   Le Jemtel, T H ^b   Logeart, D ^c   Marechaux S ^d  

^a UNIV LILLE   (France)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HÔPITAL LARIBOISIÈRE   (France)

^d UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

Author keywords

Comorbidity; Doppler echocardiography; Heart failure with preserved left ventricular ejection fraction; Pathophysiology; Prognosis

Indexed keywords

BIOLOGICAL MARKER;

BLOOD VESSEL FUNCTION; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FLUID TRANSPORT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE RELAXATION; HUMAN; HYPERTENSION; OBESITY; PATHOGENESIS; PROGNOSIS; SHORT SURVEY; SLEEP DISORDERED BREATHING; SYSTEMIC DISEASE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VENTRICLE VASCULAR COUPLING;

AGED; CAUSE OF DEATH; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HUMANS; MALE; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84862853080     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.02.004     Document Type: Short Survey

References (90)

1. Massie B., Carson P., McMurray J., Komajda M., McKelvie R., Zile M., et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008, 359:2456-2467.
2. Yusuf S., Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J.V., et al. Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-preserved trial. Lancet 2003, 362:777-781.
3. Owan T., Hodge D., Herges R., Jacobsen S., Roger V., Redfield M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
4. Klapholz M., Maurer M., Lowe A., Messineo F., Meisner J., Mitchell J., et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York heart failure registry. J Am Coll Cardiol 2004, 43:1432-1438.
5. Tribouilloy C., Rusinaru D., Mahjoub H., Soulière V., Lévy F., Peltier M., et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 2008, 29:339-347.
6. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
7. Hogg K., Swedberg K., McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004, 43:317-327.
8. Lam C.S., Lyass A., Kraigher-Krainer E., Massaro J.M., Lee D.S., Ho J.E., et al. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 2011, 124:24-30.
9. Hawkins N.M., Petrie M.C., Jhund P.S., Chalmers G.W., Dunn F.G., McMurray J.J. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009, 11:130-139.
10. Barr R.G., Bluemke D.A., Ahmed F.S., Carr J.J., Enright P.L., Hoffman E.A., et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010, 362:217-227.
11. Liang K.P., Myasoedova E., Crowson C.S., Davis J.M., Roger V.L., Karon B.L., et al. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010, 69:1665-1670.
12. Kalogeropoulos A., Georgiopoulou V., Psaty B.M., Rodondi N., Smith A.L., Harrison D.G., et al. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (health, aging, and body composition) study. J Am Coll Cardiol 2010, 55:2129-2137.
13. Butler J., Kalogeropoulos A., Georgiopoulou V., De Rekeneire N., Rodondi N., Smith A.L., et al. Serum resistin concentrations and risk of new onset heart failure in older persons: the health, aging, and body composition (Health ABC) study. Arterioscler Thromb Vasc Biol 2009, 29:1144-1149.
14. Tribouilloy C., Buiciuc O., Rusinaru D., Malaquin D., Levy F., Peltier M. Long-term outcome after a first episode of heart failure. A prospective 7-year study. Int J Cardiol 2010, 140:309-314.
15. Marechaux S., Six-Carpentier M.M., Bouabdallaoui N., Montaigne D., Bauchart J.J., Mouquet F., et al. Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction. Heart Vessels 2011, 26:313-320.
16. Henkel D.M., Redfield M.M., Weston S.A., Gerber Y., Roger V.L. Death in heart failure: a community perspective. Circ Heart Fail 2008, 1:91-97.
17. Zile M.R., Gaasch W.H., Anand I.S., Haass M., Little W.C., Miller A.B., et al. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction study (I-Preserve) trial. Circulation 2010, 121:1393-1405.
18. Haass M., Kitzman D.W., Anand I.S., Miller A., Zile M.R., Massie B.M., et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ Heart Fail 2011, 4:324-331.
19. Ennezat P.V., Marechaux S., Six-Carpentier M., Pincon C., Sediri I., Delsart P., et al. Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction. Nephrol Dial Transplant 2011, 26:3908-3913.
20. Melenovsky V., Borlaug B.A., Rosen B., Hay I., Ferruci L., Morell C.H., et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol 2007, 49:198-207.
21. Zile M., Baicu C., Gaasch W. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004, 350:1953-1959.
22. Lam C.S.P., Roger V.L., Rodeheffer R.J., Bursi F., Borlaug B.A., Ommen S.R., et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007, 115:1982-1990.
23. Maeder M.T., Thompson B.R., Brunner-La Rocca H.P., Kaye D.M. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 2010, 56:855-863.
24. Kitzman D.W., Higginbotham M.B., Cobb F.R., Sheikh K.H., Sullivan M.J. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065-1072.
25. Westermann D., Kasner M., Steendijk P., Spillmann F., Riad A., Weitmann K., et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008, 117:2051-2060.
26. Yip G.W., Zhang Q., Xie J.M., Liang Y.J., Liu Y.M., Yan B., et al. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle tracking echocardiography. Heart 2011, 97:287-294.
27. Nguyen J.S., Lakkis N.M., Bobek J., Goswami R., Dokainish H. Systolic and diastolic myocardial mechanics in patients with cardiac disease and preserved ejection fraction: impact of left ventricular filling pressure. J Am Soc Echocardiogr 2010, 23:1273-1280.
28. Lam C., Roger V., Rodeheffer R., Bursi F., Borlaug B., Ommen S., et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007, 115:1982-1990.
29. Kawaguchi M., Hay I., Fetics B., Kass D. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107:714-720.
30. Ennezat P.V., Lefetz Y., Maréchaux S., Six-Carpentier M., Deklunder G., Montaigne D., et al. Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail 2008, 14:475-480.
31. Borlaug B.A., Olson T.P., Lam C.S., Flood K.S., Lerman A., Johnson B.D., et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010, 56:845-854.
32. Hundley W.G., Bayram E., Hamilton C.A., Hamilton E.A., Morgan T.M., Darty S.N., et al. Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. AJP: Heart Circ Physiol 2006, 292:H1427-H1434.
33. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., et al. European network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
34. Balmain S., Padmanabhan N., Ferrell W.R., Morton J.J., McMurray J.J. Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. Eur J Heart Fail 2007, 9:865-871.
35. Desai A.S., Mitchell G.F., Fang J.C., Creager M.A. Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail 2009, 15:658-664.
36. Hundley W., Kitzman D., Morgan T., Hamilton C., Darty S., Stewart K., et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance*1. J Am Coll Cardiol 2001, 38:796-802.
37. Redfield M.M., Jacobsen S.J., Borlaug B.A., Rodeheffer R.J., Kass D.A. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005, 112:2254-2262.
38. de las Fuentes L., Brown A.L., Mathews S.J., Waggoner A.D., Soto P.F., Gropler R.J., et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007, 28:553-559.
39. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
40. Kramer K., Kirkman P., Kitzman D., Little W.C. Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J 2000, 140:451-455.
41. Wang L.J., Lu L., Zhang F.R., Chen Q.J., De Caterina R., Shen W.F. Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation end-products levels and decreased endogenous secretory receptor for advanced glycation end-products levels in diabetic and non-diabetic patients with heart failure. Eur J Heart Fail 2011, 13:440-449.
42. Klotz S., Hay I., Zhang G., Maurer M., Wang J., Burkhoff D. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension 2006, 47:901-911.
43. Abramov D., He K.L., Wang J., Burkhoff D., Maurer M.S. The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction. J Card Fail 2011, 17:547-555.
44. Edwards N., Ferro C., Townend J., Steeds R. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart 2008, 94:1038-1043.
45. Burkhoff D., Maurer M., Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?. Circulation 2003, 107:656.
46. Cotter G., Moshkovitz Y., Milovanov O., Salah A., Blatt A., Krakover R., et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail 2002, 4:227-234.
47. Gheorghiade M., Abraham W.T., Albert N.M., Greenberg B.H., O'Connor C.M., She L., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006, 296:2217-2226.
48. Iwanaga Y., Nishi I., Furuichi S., Noguchi T., Sase K., Kihara Y., et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006, 47:742-748.
49. Maisel A.S., McCord J., Nowak R.M., Hollander J.E., Wu A.H., Duc P., et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the breathing not properly multinational study. J Am Coll Cardiol 2003, 41:2010-2017.
50. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105:595-601.
51. Anand I.S., Rector T.S., Cleland J.G., Kuskowski M., McKelvie R.S., Persson H., et al. Prognostic value of baseline plasma aminoterminal pro-brain natriuretic peptide and its interactions with Irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE Trial. Circ Heart Fail 2011, 4:569-577.
52. Okuyan E., Uslu A., Cakar M.A., Sahin I., Onur I., Enhos A., et al. Homocysteine levels in patients with heart failure with preserved ejection fraction. Cardiology 2010, 117:21-27.
53. Niethammer M., Sieber M., von Haehling S., Anker S.D., Munzel T., Horstick G., et al. Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol 2008, 129:111-117.
54. Carrasco-Sanchez F.J., Galisteo-Almeda L., Paez-Rubio I., Martinez-Marcos F.J., Camacho-Vazquez C., Ruiz-Frutos C., et al. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction. J Card Fail 2011, 17:31-38.
55. Arques S., Ambrosi P., Gelisse R., Luccioni R., Habib G. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 2003, 42:712-716.
56. Yalcin F., Yalcin H., Kucukler N., Abraham T.P. Quantitative left ventricular contractility analysis under stress: a new practical approach in follow-up of hypertensive patients. J Hum Hypertens 2011, 25:578-584.
57. Borlaug B., Melenovsky V., Russell S., Kessler K., Pacak K., Becker L., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114:2138-2147.
58. Phan T.T., Shivu G.N., Abozguia K., Davies C., Nassimizadeh M., Jimenez D., et al. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3:29-34.
59. Wissocq L., Ennezat P.V., Mouquet F. Exercise-induced high-degree atrioventricular block. Arch Cardiovasc Dis 2009, 102:733-735.
60. Ennezat P.V., Logeart D., Berrebi A., Vincentelli A., Maréchaux S. Key role of Doppler echocardiography in the emergency management of elderly patients. Arch Cardiovasc Dis 2010, 103:115-128.
61. Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., Smiseth O.A., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009, 10:165-193.
62. Burleson A.C., N'Guyen T., Fontaine A., Levine R.A., Yoganathan A.P. A model based on dimensional analysis for noninvasive quantification of valvular regurgitation under confined and impinging conditions: in vitro pulsatile flow validation. Ultrasound Med Biol 1995, 21:899-911.
63. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7:79-108.
64. Marechaux S., Pibarot P., Ennezat P.V. Insights into functional mitral regurgitation despite preserved LVEF. Arch Cardiovasc Dis 2011, 104:131-133.
65. Maréchaux S., Pinçon C., Poueymidanette M., Verhaeghe M., Bellouin A., Asseman P., et al. Elevated left atrial pressure estimated by Doppler echocardiography is a key determinant of mitral valve tenting in functional mitral regurgitation. Heart 2010, 96:289-297.
66. Marechaux S., Neicu D.V., Braun S., Richardson M., Delsart P., Bouabdallaoui N., et al. Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction. J Card Fail 2011, 17:806-812.
67. Puwanant S., Priester T.C., Mookadam F., Bruce C.J., Redfield M.M., Chandrasekaran K. Right ventricular function in patients with preserved and reduced ejection fraction heart failure. Eur J Echocardiogr 2009, 10:733-737.
68. Guazzi M., Myers J., Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 2005, 46:1883-1890.
69. Marechaux S., Bellouin A., Polge A.S., Richardson-Lobbedez M., Lubret R., Asseman P., et al. Clinical value of exercise Doppler echocardiography in patients with cardiac-valvular disease. Arch Cardiovasc Dis 2008, 101:351-360.
70. Marechaux S., Terrade J., Biausque F., Lefetz Y., Deturck R., Asseman P., et al. Exercise-induced functional mitral regurgitation in heart failure and preserved ejection fraction: a new entity. Eur J Echocardiogr 2010, 11:E14.
71. Borlaug B.A., Nishimura R.A., Sorajja P., Lam C.S., Redfield M.M. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3:588-595.
72. Borlaug B.A., Nishimura R.A., Sorajja P., Lam C.S.P., Redfield M.M. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circulation: Heart Failure 2010, 3:588-595.
73. Amery A., Birkenhager W., Brixko P., Bulpitt C., Clement D., Deruyttere M., et al. Mortality and morbidity results from the European working party on high blood pressure in the elderly trial. Lancet 1985, 1:1349-1354.
74. Zhenfeng Z., Huilan S., Junya J., Dong L., Shan L. A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension. J Renin Angiotensin Aldosterone Syst 2011, 12:102-112.
75. Shah R.V., Desai A.S., Givertz M.M. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. J Card Fail 2010, 16:260-267.
76. Yip G.W., Wang M., Wang T., Chan S., Fung J.W., Yeung L., et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 2008, 94:573-580.
77. Kitzman D.W., Hundley W.G., Brubaker P.H., Morgan T.M., Moore J.B., Stewart K.P., et al. A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility. Circ Heart Fail 2010, 3:477-485.
78. Ahmed A., Rich M.W., Love T.E., Lloyd-Jones D.M., Aban I.B., Colucci W.S., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post-hoc analysis of the DIG trial. Eur Heart J 2006, 27:178-186.
79. Deswal A., Richardson P., Bozkurt B., Mann D.L. Results of the randomized aldosterone antagonism in heart failure with preserved ejection fraction trial (RAAM-PEF). J Card Fail 2011, 17:634-642.
80. Cohen R.S., Karlin P., Yushak M., Mancini D., Maurer M.S. The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. Congest Heart Fail 2010, 16:96-103.
81. Anker S.D., Comin Colet J., Filippatos G., Willenheimer R., Dickstein K., Drexler H., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009, 361:2436-2448.
82. Lam C.S., Roger V.L., Rodeheffer R.J., Borlaug B.A., Enders F.T., Redfield M.M. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009, 53:1119-1126.
83. Guazzi M., Vicenzi M., Arena R., Guazzi M.D. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail 2011, 4:8-17.
84. Kitzman D.W., Brubaker P., Morgan T.M., Stewart K.P., Little W.C. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail 2010, 1-9.
85. Cicero A.F., Derosa G., Bove M., Di Gregori V., Gaddi A.V., Borghi C. Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome. Eur J Cardiovasc Prev Rehabil 2009, 16:698-704.
86. Kane G.C., Xu N., Mistrik E., Roubicek T., Stanson A.W., Garovic V.D. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 2010, 25:813-820.
87. de Silva R., Nikitin N.P., Bhandari S., Nicholson A., Clark A.L., Cleland J.G. Atherosclerotic renovascular disease in chronic heart failure: should we intervene. Eur Heart J 2005, 26:1596-1605.
88. Kass D.A., Kitzman D.W., Alvarez G.E. The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design. J Card Fail 2010, 16:17-24.
89. Funck R.C., Blanc J.J., Mueller H.H., Schade-Brittinger C., Bailleul C., Maisch B., et al. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the biventricular pacing for atrioventricular block to prevent cardiac desynchronization (BioPace) study. Europace 2006, 8:629-635.
90. Yu C.M., Zhang Q., Yip G.W., Lee P.W., Kum L.C., Lam Y.Y., et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. J Am Coll Cardiol 2007, 49:97-105.